Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Clinical and pathological characteristics of congenital neuroblastoma in 15 Chinese infants: a retrospective analysis from a single-center.

Created on 22 Sep 2026

Authors

Li'ou Zhu, Ying Wu, Wen Zhang, Qiong Feng, Dengyan Chen, Lili Liu

Published in

Frontiers in medicine. Volume 13. Pages 1854318. Epub Sep 07, 2026.

Abstract

This study aims to elucidate the clinicopathological characteristics, molecular profiles, and prognostic outcomes of congenital neuroblastoma in Chinese infants.
A retrospective single-center analysis was conducted on 15 pathologically confirmed congenital neuroblastoma cases in China from 2017 to 2025. Clinical, imaging, pathological features and FISH for MYCN amplification and KMT2A rearrangement were evaluated.
The cohort included 15 patients with a male-to-female ratio of 8:7. Eight cases were detected prenatally and seven within 28 postnatal days. Most tumors (12/15) arose in the adrenal gland. Preoperative serum NSE elevation was more sensitive than VMA. All patients underwent complete resection; one received adjuvant chemotherapy and one relapsed. No MYCN amplification or KMT2A rearrangement was found.
In this single-center Chinese cohort, congenital neuroblastoma showed favorable biological behavior. Complete resection achieved good outcomes. Combination of NSE and imaging examinations is promising for postoperative prognostic evaluation and recurrence surveillance in these pediatric patients.

PMID:
42769020
Bibliographic data and abstract were imported from PubMed on 22 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement